University Health Network
Developing a biomarker for limited-stage follicular lymphoma
Our proposal focuses on a particular subtype of non-Hodgkin lymphoma, namely follicular lymphoma. We will study tumour biopsies from those patients who have disease that is localized, meaning that it is amenable to treatment using radiation therapy. Unfortunately, half of these patients experience a relapse after treatment. We propose to develop an assay that would tell us which patients are at high risk of presenting with recurrence of their lymphoma.